Dudediligence.

InMed Pharmaceuticals Inc

INMNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.3MSep ’24$1.1MDec ’24$1.3MMar ’25$1.3MJun ’25$1.1MSep ’25$820,188Dec ’25
Net income, by quarter
−$1.7MSep ’24−$2.6MDec ’24−$2.1MMar ’25−$1.8MJun ’25−$1.7MSep ’25−$2.0MDec ’25−$3.0MMar ’26−$5.8MJun ’26
Fiscal years, by the month each ended
LineJun 2022Jun 2023Jun 2024Jun 2025Jun 2026
Revenue$1.1M$4.1M$4.6M$4.9Mnone on file
Gross profit$543,546$1.4M$1.1M$1.7Mnone on file
Operating income−$18.6M−$7.9Mnone on filenone on filenone on file
Net income−$18.6M−$7.9M−$7.7M−$8.2M−$12.6M
Operating cash flow−$15.6M−$7.3M−$7.0M−$7.8M−$8.6M
Free cash flow−$15.6M−$7.4M−$7.0Mnone on filenone on file
Cash$6.2M$8.9M$6.6M$11.1M$2.2M
Shares outstanding650.7K3.3M445.9K2.0M5.3M